Kell Østerlind
Impact in
- Oncology top 0.5%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer survivorship and care
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
Papers in
- Oncology 72
- Lung Cancer Research Studies 50
- Colorectal Cancer Treatments and Studies 11
- Pancreatic and Hepatic Oncology Research 4
- Cancer survivorship and care 4
-
- Lung Cancer Diagnosis and Treatment 17
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Heine Høi Hansen (22 shared papers)P Dombernowsky (25 shared papers)Jørgen Gliemann (3 shared papers)J. Vinten (2 shared papers)Fred R. Hirsch (13 shared papers)Per Kragh Andersen (3 shared papers)Mark Alexander Berner-Hansen (9 shared papers)Daniel C. Ihde (3 shared papers)
- Journals
- Lung Cancer (15 papers)Annals of Oncology (10 papers)British Journal of Cancer (9 papers)Journal of Clinical Oncology (5 papers)Acta Oncologica (4 papers)
- Partner nations
- DenmarkUnited KingdomBelgium
In The Last Decade
Kell Østerlind
102 papers receiving 6k citations
Kell Østerlind's Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 3k
- Pulmonary and Respiratory Medicine 2.1k
- Cancer Research 398
- Geriatrics and Gerontology 46
- Biochemistry 81
Countries citing papers authored by Kell Østerlind
This map shows the geographic impact of Kell Østerlind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kell Østerlind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kell Østerlind more than expected).
Fields of papers citing papers by Kell Østerlind
This network shows the impact of papers produced by Kell Østerlind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kell Østerlind. The network helps show where Kell Østerlind may publish in the future.
Co-authors
The 25 scholars most cited alongside Kell Østerlind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial Hit paper breakdown → | 2008 | 1071 |
| 2 | A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer Hit paper breakdown → | 1992 | 1026 |
| 3 | 1972 | 340 | |
| 4 | Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. | 1994 | 265 |
| 5 | 1995 | 226 | |
| 6 | 1989 | 209 | |
| 7 | 1987 | 186 | |
| 8 | 1976 | 132 | |
| 9 | 2016 | 109 | |
| 10 | 2013 | 108 | |
| 11 | 1986 | 105 | |
| 12 | 1983 | 95 | |
| 13 | 1987 | 89 | |
| 14 | 2013 | 86 | |
| 15 | 1996 | 84 | |
| 16 | 1986 | 79 | |
| 17 | 2011 | 77 | |
| 18 | Staging and prognostic factors in small cell carcinoma of the lung. | 1983 | 76 |
| 19 | 2013 | 76 | |
| 20 | 2016 | 74 |
About Kell Østerlind
Kell Østerlind is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Biochemistry and Immunology, having authored 105 papers that have together received 6.4k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (50 papers), Lung Cancer Diagnosis and Treatment (17 papers), Colorectal Cancer Treatments and Studies (11 papers), Lung Cancer Treatments and Mutations (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cancer survivorship and care (4 papers), Protease and Inhibitor Mechanisms (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Oncology (3k citations), Pulmonary and Respiratory Medicine (2.1k citations), Cancer Research (398 citations), Geriatrics and Gerontology (46 citations) and Biochemistry (81 citations). Kell Østerlind has collaborated with scholars based in Denmark, United Kingdom and Belgium. Frequent co-authors include Heine Høi Hansen, P Dombernowsky, Jørgen Gliemann, J. Vinten, Fred R. Hirsch, Per Kragh Andersen, Mark Alexander Berner-Hansen, Daniel C. Ihde, Steen Gammeltoft and Michael C. Perry. Their work appears in journals such as Lung Cancer, Annals of Oncology, British Journal of Cancer, Journal of Clinical Oncology and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.